R. Sayer Kevin's most recent trade in Dexcom Inc was a trade of 32,498 Common Stock done at an average price of $70.4 . Disclosure was reported to the exchange on March 12, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 70.38 per share. | 12 Mar 2025 | 32,498 | 372,029 (0%) | 0% | 70.4 | 2,287,212 | Common Stock |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2025 | 85,490 | 404,527 (0%) | 0% | 0 | Common Stock | |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2025 | 68,503 | 352,396 (0%) | 0% | 0 | Common Stock | |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 86.91 per share. | 28 Jan 2025 | 33,359 | 319,037 (0%) | 0% | 86.9 | 2,899,367 | Common Stock |
| DexCom | Kevin R. Sayer | Director, President CEO and Chairman | Sale of securities on an exchange or to another person at price $ 137.96 per share. | 08 Apr 2024 | 27,272 | 306,254 (0%) | 0% | 138.0 | 3,762,489 | Common Stock |
| DexCom | Kevin R. Sayer | Director, President CEO and Chairman | Sale of securities on an exchange or to another person at price $ 138.71 per share. | 08 Apr 2024 | 22,361 | 283,893 (0%) | 0% | 138.7 | 3,101,647 | Common Stock |
| DexCom | Kevin R. Sayer | Director, President CEO and Chairman | Sale of securities on an exchange or to another person at price $ 134.41 per share. | 12 Mar 2024 | 29,675 | 384,858 (0%) | 0% | 134.4 | 3,988,638 | Common Stock |
| DexCom | Kevin R. Sayer | Director, President CEO and Chairman | Sale of securities on an exchange or to another person at price $ 133.55 per share. | 12 Mar 2024 | 20,930 | 336,465 (0%) | 0% | 133.5 | 2,795,145 | Common Stock |
| DexCom | Kevin R. Sayer | Director, President CEO and Chairman | Sale of securities on an exchange or to another person at price $ 132.43 per share. | 12 Mar 2024 | 14,993 | 357,395 (0%) | 0% | 132.4 | 1,985,571 | Common Stock |
| DexCom | Kevin R. Sayer | Director, President CEO and Chairman | Sale of securities on an exchange or to another person at price $ 131.47 per share. | 12 Mar 2024 | 12,470 | 372,388 (0%) | 0% | 131.5 | 1,639,427 | Common Stock |
| DexCom | Kevin R. Sayer | Director, President CEO and Chairman | Sale of securities on an exchange or to another person at price $ 134.07 per share. | 12 Mar 2024 | 2,939 | 333,526 (0%) | 0% | 134.1 | 394,023 | Common Stock |
| DexCom | Kevin R. Sayer | Director, President CEO and Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2024 | 51,692 | 414,533 (0%) | 0% | 0 | Common Stock | |
| DexCom | R. Sayer Kevin | Director, President, CEO and Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 72,709 | 400,166 (0%) | 0% | 0.0 | 73 | Common Stock |
| DexCom | R. Sayer Kevin | Director, President, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 123.63 per share. | 12 Jan 2024 | 37,325 | 362,841 (0%) | 0% | 123.6 | 4,614,669 | Common Stock |
| DexCom | Kevin R. Sayer | Director, President CEO and Chairman of | Sale of securities on an exchange or to another person at price $ 114.39 per share. | 03 Apr 2023 | 11,218 | 331,056 (0%) | 0% | 114.4 | 1,283,255 | Common Stock |
| DexCom | Kevin R. Sayer | Director, President CEO and Chairman of | Sale of securities on an exchange or to another person at price $ 113.83 per share. | 03 Apr 2023 | 5,995 | 342,274 (0%) | 0% | 113.8 | 682,423 | Common Stock |
| DexCom | Kevin R. Sayer | Director, President CEO and Chairman of | Sale of securities on an exchange or to another person at price $ 115.70 per share. | 03 Apr 2023 | 3,599 | 327,457 (0%) | 0% | 115.7 | 416,391 | Common Stock |
| DexCom | Kevin R. Sayer | Director, President CEO and Chairman of | Sale or transfer of securities back to the company at price $ 111.40 per share. | 10 Mar 2023 | 17,302 | 368,457 (0%) | 0% | 111.4 | 1,927,425 | Common Stock |
| DexCom | Kevin R. Sayer | Director, President CEO and Chairman of | Sale or transfer of securities back to the company at price $ 111.40 per share. | 10 Mar 2023 | 11,047 | 348,269 (0%) | 0% | 111.4 | 1,230,625 | Common Stock |
| DexCom | Kevin R. Sayer | Director, President CEO and Chairman of | Sale or transfer of securities back to the company at price $ 111.40 per share. | 10 Mar 2023 | 9,141 | 359,316 (0%) | 0% | 111.4 | 1,018,298 | Common Stock |
| DexCom | Kevin R. Sayer | Director, President CEO and Chairman of | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2023 | 54,422 | 385,759 (0%) | 0% | 0.0 | 54 | Common Stock |
| DexCom | Kevin R. Sayer | Director, President CEO and Chairman of | Sale of securities on an exchange or to another person at price $ 109.83 per share. | 01 Mar 2023 | 31,203 | 338,598 (0%) | 0% | 109.8 | 3,426,907 | Common Stock |
| DexCom | Kevin R. Sayer | Director, President CEO and Chairman of | Sale of securities on an exchange or to another person at price $ 110.41 per share. | 01 Mar 2023 | 7,261 | 331,337 (0%) | 0% | 110.4 | 801,704 | Common Stock |
| DexCom | Kevin R. Sayer | Director, President CEO and Chairman of | Sale of securities on an exchange or to another person at price $ 106.06 per share. | 30 Jan 2023 | 47,693 | 378,952 (0%) | 0% | 106.1 | 5,058,148 | Common Stock |
| DexCom | Kevin R. Sayer | Director, President CEO and Chairman of | Sale of securities on an exchange or to another person at price $ 106.65 per share. | 30 Jan 2023 | 9,151 | 369,801 (0%) | 0% | 106.7 | 975,975 | Common Stock |
| DexCom | Kevin R. Sayer | Director, President CEO and Chairman of | Sale of securities on an exchange or to another person at price $ 105.75 per share. | 20 Jan 2023 | 45,607 | 426,645 (0%) | 0% | 105.7 | 4,822,872 | Common Stock |
| DexCom | Kevin R. Sayer | Director, President CEO and Chairman of | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2023 | 90,720 | 472,252 (0%) | 0% | 0 | Common Stock | |
| DexCom | Kevin R. Sayer | Director, President CEO and Chairman of | Gift of securities by or to the insider at price $ 0.00 per share. | 18 Jan 2023 | 10,000 | 381,532 (0%) | 0% | 0 | Common Stock | |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 412.27 per share. | 15 Mar 2022 | 450 | 98,183 (0%) | 0% | 412.3 | 185,522 | Common Stock |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 405.84 per share. | 15 Mar 2022 | 445 | 100,438 (0%) | 0% | 405.8 | 180,599 | Common Stock |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 410.00 per share. | 15 Mar 2022 | 445 | 99,038 (0%) | 0% | 410 | 182,450 | Common Stock |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 411.25 per share. | 15 Mar 2022 | 405 | 98,633 (0%) | 0% | 411.2 | 166,556 | Common Stock |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 407.00 per share. | 15 Mar 2022 | 405 | 100,033 (0%) | 0% | 407 | 164,835 | Common Stock |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 408.89 per share. | 15 Mar 2022 | 400 | 99,483 (0%) | 0% | 408.9 | 163,556 | Common Stock |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 416.42 per share. | 15 Mar 2022 | 150 | 97,883 (0%) | 0% | 416.4 | 62,463 | Common Stock |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 407.60 per share. | 15 Mar 2022 | 150 | 99,883 (0%) | 0% | 407.6 | 61,140 | Common Stock |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 414.99 per share. | 15 Mar 2022 | 100 | 98,033 (0%) | 0% | 415.0 | 41,499 | Common Stock |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 413.52 per share. | 15 Mar 2022 | 50 | 98,133 (0%) | 0% | 413.5 | 20,676 | Common Stock |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2022 | 16,251 | 110,868 (0%) | 0% | 0.0 | 16 | Common Stock |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Sale or transfer of securities back to the company at price $ 406.06 per share. | 08 Mar 2022 | 4,473 | 103,246 (0%) | 0% | 406.1 | 1,816,292 | Common Stock |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Sale or transfer of securities back to the company at price $ 406.06 per share. | 08 Mar 2022 | 3,149 | 107,719 (0%) | 0% | 406.1 | 1,278,673 | Common Stock |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Sale or transfer of securities back to the company at price $ 406.06 per share. | 08 Mar 2022 | 2,363 | 100,883 (0%) | 0% | 406.1 | 959,512 | Common Stock |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 418.04 per share. | 14 Feb 2022 | 3,000 | 94,617 (0%) | 0% | 418.0 | 1,254,120 | Common Stock |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 38,586 | 117,291 (0%) | 0% | 0 | Common Stock | |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 435.06 per share. | 18 Jan 2022 | 19,674 | 97,617 (0%) | 0% | 435.1 | 8,559,370 | Common Stock |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 438.81 per share. | 18 Jan 2022 | 3,000 | 78,705 (0%) | 0% | 438.8 | 1,316,430 | Common Stock |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 538.15 per share. | 15 Dec 2021 | 527 | 82,384 (0%) | 0% | 538.1 | 283,603 | Common Stock |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 534.84 per share. | 15 Dec 2021 | 500 | 83,432 (0%) | 0% | 534.8 | 267,422 | Common Stock |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 531.87 per share. | 15 Dec 2021 | 300 | 84,032 (0%) | 0% | 531.9 | 159,560 | Common Stock |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 537.08 per share. | 15 Dec 2021 | 271 | 82,911 (0%) | 0% | 537.1 | 145,548 | Common Stock |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 536.01 per share. | 15 Dec 2021 | 250 | 83,182 (0%) | 0% | 536.0 | 134,002 | Common Stock |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 528.06 per share. | 15 Dec 2021 | 200 | 84,505 (0%) | 0% | 528.1 | 105,613 | Common Stock |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 541.39 per share. | 15 Dec 2021 | 200 | 81,805 (0%) | 0% | 541.4 | 108,278 | Common Stock |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 540.40 per share. | 15 Dec 2021 | 200 | 82,005 (0%) | 0% | 540.4 | 108,081 | Common Stock |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 539.32 per share. | 15 Dec 2021 | 179 | 82,205 (0%) | 0% | 539.3 | 96,539 | Common Stock |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 529.78 per share. | 15 Dec 2021 | 148 | 84,357 (0%) | 0% | 529.8 | 78,407 | Common Stock |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 532.92 per share. | 15 Dec 2021 | 100 | 83,932 (0%) | 0% | 532.9 | 53,292 | Common Stock |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 543.84 per share. | 15 Dec 2021 | 50 | 81,705 (0%) | 0% | 543.8 | 27,192 | Common Stock |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 542.06 per share. | 15 Dec 2021 | 50 | 81,755 (0%) | 0% | 542.1 | 27,103 | Common Stock |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 530.44 per share. | 15 Dec 2021 | 25 | 84,332 (0%) | 0% | 530.4 | 13,261 | Common Stock |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Gift of securities by or to the insider at price $ 0.00 per share. | 15 Nov 2021 | 3,000 | 87,705 (0%) | 0% | 0 | Common Stock | |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 647.92 per share. | 15 Nov 2021 | 1,350 | 85,683 (0%) | 0% | 647.9 | 874,695 | Common Stock |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 649.02 per share. | 15 Nov 2021 | 878 | 84,805 (0%) | 0% | 649.0 | 569,838 | Common Stock |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 645.01 per share. | 15 Nov 2021 | 250 | 87,233 (0%) | 0% | 645.0 | 161,252 | Common Stock |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 644.59 per share. | 15 Nov 2021 | 222 | 87,483 (0%) | 0% | 644.6 | 143,099 | Common Stock |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 646.58 per share. | 15 Nov 2021 | 200 | 87,033 (0%) | 0% | 646.6 | 129,315 | Common Stock |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 654.00 per share. | 15 Nov 2021 | 50 | 84,705 (0%) | 0% | 654 | 32,700 | Common Stock |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 652.36 per share. | 15 Nov 2021 | 50 | 84,755 (0%) | 0% | 652.4 | 32,618 | Common Stock |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 546.71 per share. | 15 Oct 2021 | 1,246 | 94,460 (0%) | 0% | 546.7 | 681,205 | Common Stock |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 545.84 per share. | 15 Oct 2021 | 999 | 95,706 (0%) | 0% | 545.8 | 545,294 | Common Stock |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 547.76 per share. | 15 Oct 2021 | 939 | 93,521 (0%) | 0% | 547.8 | 514,344 | Common Stock |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 550.93 per share. | 15 Oct 2021 | 851 | 91,869 (0%) | 0% | 550.9 | 468,839 | Common Stock |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 548.70 per share. | 15 Oct 2021 | 681 | 92,840 (0%) | 0% | 548.7 | 373,668 | Common Stock |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 555.71 per share. | 15 Oct 2021 | 614 | 90,705 (0%) | 0% | 555.7 | 341,208 | Common Stock |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 554.73 per share. | 15 Oct 2021 | 350 | 91,319 (0%) | 0% | 554.7 | 194,154 | Common Stock |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 553.14 per share. | 15 Oct 2021 | 200 | 91,669 (0%) | 0% | 553.1 | 110,628 | Common Stock |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 549.95 per share. | 15 Oct 2021 | 120 | 92,720 (0%) | 0% | 550.0 | 65,994 | Common Stock |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 541.88 per share. | 15 Sep 2021 | 1,252 | 98,250 (0%) | 0% | 541.9 | 678,438 | Common Stock |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 537.45 per share. | 15 Sep 2021 | 1,050 | 101,255 (0%) | 0% | 537.4 | 564,321 | Common Stock |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 543.18 per share. | 15 Sep 2021 | 932 | 97,318 (0%) | 0% | 543.2 | 506,242 | Common Stock |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 539.59 per share. | 15 Sep 2021 | 700 | 100,142 (0%) | 0% | 539.6 | 377,711 | Common Stock |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 540.92 per share. | 15 Sep 2021 | 640 | 99,502 (0%) | 0% | 540.9 | 346,187 | Common Stock |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 544.07 per share. | 15 Sep 2021 | 613 | 96,705 (0%) | 0% | 544.1 | 333,513 | Common Stock |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 538.63 per share. | 15 Sep 2021 | 413 | 100,842 (0%) | 0% | 538.6 | 222,456 | Common Stock |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 536.49 per share. | 15 Sep 2021 | 400 | 102,305 (0%) | 0% | 536.5 | 214,595 | Common Stock |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 541.36 per share. | 09 Sep 2021 | 2,982 | 102,705 (0%) | 0% | 541.4 | 1,614,336 | Common Stock |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 541.26 per share. | 09 Sep 2021 | 35 | 105,687 (0%) | 0% | 541.3 | 18,944 | Common Stock |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 376.33 per share. | 03 May 2021 | 2,543 | 108,714 (0%) | 0% | 376.3 | 957,014 | Common Stock |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 386.04 per share. | 03 May 2021 | 1,331 | 105,722 (0%) | 0% | 386.0 | 513,819 | Common Stock |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 382.48 per share. | 03 May 2021 | 500 | 107,353 (0%) | 0% | 382.5 | 191,240 | Common Stock |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 376.98 per share. | 03 May 2021 | 487 | 108,227 (0%) | 0% | 377.0 | 183,590 | Common Stock |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 384.91 per share. | 03 May 2021 | 300 | 107,053 (0%) | 0% | 384.9 | 115,473 | Common Stock |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 377.97 per share. | 03 May 2021 | 248 | 107,979 (0%) | 0% | 378.0 | 93,737 | Common Stock |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 378.99 per share. | 03 May 2021 | 126 | 107,853 (0%) | 0% | 379.0 | 47,753 | Common Stock |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 366.84 per share. | 05 Apr 2021 | 3,567 | 112,436 (0%) | 0% | 366.8 | 1,308,536 | Common Stock |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 365.67 per share. | 05 Apr 2021 | 1,475 | 116,003 (0%) | 0% | 365.7 | 539,369 | Common Stock |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 367.41 per share. | 05 Apr 2021 | 1,179 | 111,257 (0%) | 0% | 367.4 | 433,177 | Common Stock |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 362.92 per share. | 10 Mar 2021 | 14,044 | 117,478 (0%) | 0% | 362.9 | 5,096,806 | Common Stock |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2021 | 13,445 | 135,379 (0%) | 0% | 0.0 | 13 | Common Stock |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Mar 2021 | 10,000 | 121,934 (0%) | 0% | 0 | Common Stock | |
| DexCom | Kevin R. Sayer | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 362.29 per share. | 08 Mar 2021 | 1,127 | 132,296 (0%) | 0% | 362.3 | 408,304 | Common Stock |